RegMed Investors’ (RMi) closing bell; Celgene’s (CELG) acquisition renews interest in cell therapy

January 22, 2018 5:47pm

As sector leaders’ jump with percentage (%) gains while smaller caps incrementally slip to the downside while the iShares Nasdaq Biotechnology ETF (IBB) was up 3.14%

Cellectis SA (CLLS +12.2%), bluebird bio (BLUE +13.6%), Sangamo Therapeutics (SGMO + 9.3%), Fate Therapeutics (FATE +12.48 %), uniQure (QURE +9.56%), Spark Therapeutics (ONCE +11.88%) and Bellicum Pharmaceuticals (BLCM +9.49%) are up on light volume.

The question is WHAT to HOLD (on to)?

The market rebounds after a shutdown reopened government for three weeks

Pre-open indications: 5 hits and 1 miss

Out and about: The Biostage (BSTG +$0.29) chronicles … don’t be fooled by surges!

Monday’s results have implications to Tuesday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

Henry’omics:

From the pre-open’s newsletter, “…riding the upside as Celgene (CELG) prices acquisition of Juno Therapeutics (JUNO) at $87 per share or $9 B. Momentum is a force gained by moving objects – The iShares Nasdaq Biotechnology (IBB +0.89%), the SPDR S&P Biotech ETF (XBI +1.61%); the Health Care Select Sector SPDR ETF (XLV +0.06%) while the iShares Russell 2000 (IWM) is indicating a NEGATIVE -0.16% in Monday’s pre-open. Unfortunately, other record gains have seen some losses with directionless pricing and diffused volatility are tainting the sentiment. We are also seeing decreases in volume and increased volatility.”

Good day as traders chase other ups in reference to MOST sector equities!

The advance/decline line scenario of 40 SCGT & RT covered companies:   

·         The open was positive with an A/DL of 23/14 and 2 flat ;

·         The mid-day was positive with an A/DL of 26/12 and 2 flat;

·         The close was positive  with an A/DL of26/9 and 5 flat;

Pre-open indications:

• Applied Genetic Technologies (AGTC) closed up +$0.05 - miss;
• Bellicum Pharmaceuticals (BLCM) closed up +$0.74 – hit;
• bluebird bio (BLUE) closed up +$18.70 – hit;
• Intrexon (XON) closed up +$0.66 – hit;
• Juno Therapeutics (JUNO) closed up +$18.19 – hit;
• uniQure (QURE) closed up +$1.72 – hit;

MY working trend lines:

… The greatest volume to the downside:  RENE.L, NWBO, FCSC, ONVO and IMUC

… Upside volume was weighted to:  JUNO, XON, BLUE, SGMO and BLCM

… Biggest $ downside: AXGN (-$9.35), OSIR (-$0.275), MESO (-$0.10), RENE.L (-$0.05) and ONVO (-$0.03)

… Largest $ upside:  BLUE (+$18.70), JUNO (+$18.19), ONCE (+$6.09), CLLS (+$3.01) and QURE (+1.72)

… Flat: BTX, HSGX, AST, KOOL and PSTI  

Out and about:

Biostage (BSTGD) This management team WIPED OUT 20 M of holder’s shares and investment!

Opened at $2.70 (previous closed $2.70) closed +$0.29 or +10.74% in a day’s range of $2.51 to $2.99 with low 10,234 shares traded.  This follows the projected $1.32 post the 1-to-20 reverse split – a $4 M in-flow just followed a $30 M investment loss incurring a $47 M deficit! It was down -$0.14 at 12:45 am …

NO scientists, a CEO, CFO and 2 accountants don’t make a company who couldn’t pay their rent or communicate their issues to past “fleeced” shareholders …

I am NOT “eating” my negative declaration, my OPINION is still “COVER UP of male and female harassment and corporate MISDEEDS “by members of management team!

What did happen to (reasons) and the story “around” the IND NOT being filed and the cmo and president leaving the company? NEVER forget the storyline of the 2 broken financings before the reverse split!

http://app.quotemedia.com/data/downloadFiling?webmasterId=101533&ref=11980760&type=HTML&symbol=BSTGD&companyName=Biostage&formType=3&dateFiled=2018-01-10&cik=0001563665 – VERY interesting, NO mention of BSTG’s executives!

It’s a day trader’s dream, while it lasts – WHAT real investors are in?

Daily analytics:

Major stock market indexes finished at records Monday as the Senate approved a procedural bill that clears the way to ending a shutdown of the U.S. government.

·         The S&P 500 SPX, +0.81% rose 22.67 points, or 0.8%, to 2,832.97.

·         The NASDAQ was up 71.65 points, or 1%, at 7,408.03, on the back of strong biotechnology stocks. The iShares Nasdaq Biotechnology ETF (IBB) was up 3.14%, fueled by a flurry of merger news in the industry.

·         The Dow gained 142.88 points, or 0.6%, to 26,214.60.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, Monday traded at 11.03, down -2.13% …

• Friday traded at 11.20, down -8.35% after Thursday traded at 12.22, up +2.60% after Wednesday traded at 11.91, up +2.14% after Tuesday traded at 11.66, up +14.76% after last Monday was a holiday …

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Monday was up +0.53%

·         Friday was up +1.32%

·         Thursday  -0.70%

·         Wednesday +0.96%

·         Tuesday was -1.25%

·         Last Monday was a market holiday;

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Monday was up +3.14%

·         Friday was up +0.66%

·         Thursday was down -0.13%

·         Wednesday was up +0.73%

·         Tuesday was -1.38%

·         Last Monday was a holiday;

The count - decliners versus gainers:

……. look at the differences in decliners:

·         Monday’s decliners ranged from -0.36% <BLFS -$0.02> to -12% <NWBO -$0.02> in 9 equities;

·         Friday’s decliners ranged from -0.06% <QURE -$0.01> to -7.88% <ISCO -$0.13> in 18 equities;

·         Thursday’s decliners ranged from -0.37% <STML -$0.05> to -9.68% <RENE.L -$0.15> in 20 equities;

·         Wednesday’s decliners ranged from -0.12% <BLCM -$0.01> to -6.75% <ISCO -$0.11> in 18 equities;

·         Tuesday’s decliners ranged from -0.61% <ISCO -$0.01> to -9.03% <RGNX -$2.75> in 31 equities;

·         Last Monday was a holiday;

Versus

… Look at the percentage’s (%) and spreads …

·         Monday’s gainers ranged from +0.52% <ATHX +$0.01> to +26.82% <JUNO +$18.19> in 26 equities;

·         Friday’s gainers ranged from +0.67% <PSTI +$0.01> to +5.80% <ADRO +$0.40> in 21 equities;

·         Thursday’s gainers ranged from +0.17% <MESO +$0.01> to +18.31% <CYTX +$0.06> in 15 equities;

·         Wednesday’s gainers ranged from +0.33% <VSTM +$0.01> to +53.86% <JUNO +$23.65> in 19 equities;

·         Tuesday’s gainers ranged from +0.58% <MDXG +$0.08> to +10.13% <ADVM +$0.40> in 9 equities;

·         Monday was a holiday;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.